Epsilon Healthcare Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EPN.AX research report →
Price Chart
About the company
Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several areas: manufacturing and distributing a range of hydroponic supplies, including equipment, materials, and vital nutrients; developing and providing medicinal cannabis products; and offering comprehensive, ready-to-implement solutions for cannabis cultivation. The company officially rebranded from THC Global Group Limited to Epsilon Healthcare Limited in February 2021.
- CEO
- Peter Giannopoulos
- IPO
- 2017
- Employees
- 14
- HQ
- Southport, QLD, AU
Get TickerSpark's AI analysis on EPN.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.28M
- P/E
- -11.60
- PEG
- -0.16
- P/S
- 0.91
- P/B
- 5.76
- EV/EBITDA
- -11.54
- Div Yield
- 0.00%
- Gross Margin
- 33.42%
- Op Margin
- -18.04%
- Net Margin
- -7.13%
- ROE
- -1301.30%
- ROIC
- -7.72%
Latest fiscal year · YoY change
- Revenue
- $9.39M+67.7%
- Gross Profit
- $2.09M-49.8%
- Op Income
- $-2,377,387
- Net Income
- $-1,278,503+60.6%
- EPS
- $-0.00+60.9%
- OCF Growth
- +8.2%
- FCF Growth
- +5.9%
- 52W High
- $0.04
- 52W Low
- $0.02
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- 0.77
- RSI (14)
- 76
- Avg Volume
- 141.28K
No earnings-call transcripts are available for EPN.AX yet.
- Free Float
- 90.8%
- Shares Outstanding
- 389.10M
- Float Shares
- 353.44M
Our EPN.AX coverage
Recent articles, reports, and earnings notes.
No research on EPN.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EPN.AX report →